Position in ALKS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$57,497,573
+$20,848,352 QoQ
Shares Held
1,097,282
+5.9% QoQ
Ownership
0.654%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 421 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
This page
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,497,573 | 1,097,282 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $36,649,221 | 1,036,460 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $30,052,950 | 1,074,087 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $42,733,980 | 1,424,466 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $43,941,692 | 1,535,886 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $55,810,233 | 1,690,195 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $61,448,324 | 2,136,590 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $61,381,224 | 2,192,970 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $58,373,426 | 2,422,134 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $78,026,859 | 2,882,411 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $91,181,096 | 3,286,990 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $77,344,455 | 2,761,316 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $83,087,941 | 2,654,567 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $74,888,674 | 2,656,569 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $65,268,764 | 2,497,848 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $55,739,181 | 2,496,157 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $74,620,817 | 2,504,895 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $68,072,069 | 2,587,308 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $67,559,806 | 2,904,549 | Shares | Defined | 2022-02-11 | |
| 2021-06-30 | $66,007,983 | 2,692,006 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $39,845,614 | 2,133,063 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $25,819,905 | 1,294,231 | Shares | Defined | 2021-02-09 | |
| 2020-06-30 | $10,999,625 | 566,699 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $8,061,109 | 559,023 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||